Suppliers / Kunming Guiyan Pharmaceutical

Kunming Guiyan Pharmaceutical

China Updated 9 July 2026

Kunming Guiyan Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files and 3 valid CEPs across a filed portfolio of 3 molecules.

4
active US DMFs
3
valid CEPs
1
registered plants
1
filings across 1 regulators

Registered plants

Site FDA FEI
Kunming, China Not on file

What they file, and where

Molecule Regulators Docs
Carboplatin EDQM, US FDA 3
Oxaliplatin EDQM, US FDA 3
Cisplatin EDQM 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None

Comparing suppliers?

Choose your molecules and target markets. Kunming Guiyan Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability